Sector: health
Conviction from: S&P
52-week range: 101.00247.49
Provides kidney-care services, primarily operating a large network of outpatient dialysis centers treating patients with chronic kidney failure in the United States and abroad.
5 tracked filer(s) hold this · 1 opened, 2 added, 2 trimmed in 30-SEP-2026
Aggregate 13FScore 59 — mean of 5 scored holder(s) · buyers (new/add) avg 57. Higher = the smart money in this name has the better track record.
| Filer | 13FScore | This quarter | Shares | Value | % of their book |
|---|
| Ancora | 42 | New buy | 24 | $4,198 | 0.0% |
| Steve Cohen / Point72 | 75 | Added +5225% | 591,107 | $103,396,436 | 0.1% |
| Bridgewater | 55 | Added +255% | 39,079 | $6,835,699 | 0.0% |
| Warren Buffett / Berkshire Hathaway | 63 | Trimmed -1% | 28,697,229 | $5,019,719,296 | 1.7% |
| Paul Tudor Jones / Tudor | 61 | Trimmed -23% | 52,400 | $9,165,808 | 0.0% |
Beyond 13F — activists, insiders, politicians & research
1 disclosed trade(s) by 1 filer(s).
2 disclosed trade(s) by 1 filer(s).
| Report | Date | Stance |
|---|
| #102 — GLP-1s: The Second Serving - Revisiting our GLP-1 Basket | 2025-07-24 | SHORT |
| #84 — Market Memo: Healthcare's AI-Powered Trump Card | 2025-02-09 | SHORT |